- Ongoing, recruitingTherapeutic exploratory (Phase II)
Dose Study of Tranexamic Acid in Total Hip Replacement to Reduce Postoperative Hemoglobin Loss. A Phase 2 Randomized Double-blind Monocentric Study. The PRADO study
This study looks at how different doses of a medicine called tranexamic acid can help reduce blood loss during and after hip replacement surgery. It aims to find the safest and most effective amount to use, helping patients recover better.
For: Arthropathy of HipFrance - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Does high-dose vitamin B3 supplementation prevent major adverse kidney events during septic shock? A multicenter randomized controlled study.
This study looks at whether a high dose of vitamin B3 can help prevent serious kidney problems in very sick patients called "septic shock." It compares vitamin B3 to a dummy treatment to see if it helps reduce deaths or the need for kidney dialysis.
For: adverse kidney events during septic shockFrance - AuthorisedTherapeutic confirmatory (Phase III)
Comparison of Landiolol versus standard of care for prevention of mortality in patients hospitalized for a septic shock with hypercontractlity: an open label prospective randomized study
This study compares a new medicine called Landiolol with usual treatment for very sick patients in intensive care with a serious infection (sepsis) and a fast, overworking heart. It aims to see if Landiolol can improve survival at 28 days for these patients.
For: patients hospitalized for a septic shock with hypercontractlityFrance